Low raltegravir concentration in cerebrospinal fluid in patients with ABCG2 genetic variants

Kiyoto Tsuchiya, Tsunefusa Hayashida, Akinobu Hamada, Shingo Kato, Shinichi Oka, Hiroyuki Gatanaga

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Adenosine triphosphate-binding cassette transporter G2 (ABCG2) is expressed on the cerebrospinal fluid (CSF) side of choroid plexus epithelial cells, which form the blood-CSF barrier. Raltegravir was recently identified as a substrate of ABCG2. In the present study, we analyzed the relationship between single-nucleotide polymorphisms of ABCB1 and ABCG2 genes and raltegravir concentrations in 31 plasma and 14 CSF samples of HIV-infected patients treated with raltegravir-containing regimens. The mean CSF raltegravir concentration was significantly lower in CA (25.5 ng/mL) and AA (<10 ng/mL) genotypes at position 421 in ABCG2 gene compared with CC (103.6 ng/mL) genotype holders (P = 0.016).

Original languageEnglish
Pages (from-to)484-486
Number of pages3
JournalJournal of Acquired Immune Deficiency Syndromes
Volume66
Issue number5
DOIs
Publication statusPublished - 2014 Aug 15

Fingerprint

Cerebrospinal Fluid
Adenosine Triphosphate
Genotype
Choroid Plexus
Genes
Single Nucleotide Polymorphism
Epithelial Cells
HIV
Raltegravir Potassium

Keywords

  • Adenosine triphosphate-binding cassette transporter G2
  • Antiretroviral therapy
  • Blood-cerebrospinal fluid barrier
  • Cerebrospinal fluid concentrations
  • Raltegravir

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Low raltegravir concentration in cerebrospinal fluid in patients with ABCG2 genetic variants. / Tsuchiya, Kiyoto; Hayashida, Tsunefusa; Hamada, Akinobu; Kato, Shingo; Oka, Shinichi; Gatanaga, Hiroyuki.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 66, No. 5, 15.08.2014, p. 484-486.

Research output: Contribution to journalArticle

Tsuchiya, Kiyoto ; Hayashida, Tsunefusa ; Hamada, Akinobu ; Kato, Shingo ; Oka, Shinichi ; Gatanaga, Hiroyuki. / Low raltegravir concentration in cerebrospinal fluid in patients with ABCG2 genetic variants. In: Journal of Acquired Immune Deficiency Syndromes. 2014 ; Vol. 66, No. 5. pp. 484-486.
@article{20836ea9236448de8bc51c37e325203c,
title = "Low raltegravir concentration in cerebrospinal fluid in patients with ABCG2 genetic variants",
abstract = "Adenosine triphosphate-binding cassette transporter G2 (ABCG2) is expressed on the cerebrospinal fluid (CSF) side of choroid plexus epithelial cells, which form the blood-CSF barrier. Raltegravir was recently identified as a substrate of ABCG2. In the present study, we analyzed the relationship between single-nucleotide polymorphisms of ABCB1 and ABCG2 genes and raltegravir concentrations in 31 plasma and 14 CSF samples of HIV-infected patients treated with raltegravir-containing regimens. The mean CSF raltegravir concentration was significantly lower in CA (25.5 ng/mL) and AA (<10 ng/mL) genotypes at position 421 in ABCG2 gene compared with CC (103.6 ng/mL) genotype holders (P = 0.016).",
keywords = "Adenosine triphosphate-binding cassette transporter G2, Antiretroviral therapy, Blood-cerebrospinal fluid barrier, Cerebrospinal fluid concentrations, Raltegravir",
author = "Kiyoto Tsuchiya and Tsunefusa Hayashida and Akinobu Hamada and Shingo Kato and Shinichi Oka and Hiroyuki Gatanaga",
year = "2014",
month = "8",
day = "15",
doi = "10.1097/QAI.0000000000000222",
language = "English",
volume = "66",
pages = "484--486",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Low raltegravir concentration in cerebrospinal fluid in patients with ABCG2 genetic variants

AU - Tsuchiya, Kiyoto

AU - Hayashida, Tsunefusa

AU - Hamada, Akinobu

AU - Kato, Shingo

AU - Oka, Shinichi

AU - Gatanaga, Hiroyuki

PY - 2014/8/15

Y1 - 2014/8/15

N2 - Adenosine triphosphate-binding cassette transporter G2 (ABCG2) is expressed on the cerebrospinal fluid (CSF) side of choroid plexus epithelial cells, which form the blood-CSF barrier. Raltegravir was recently identified as a substrate of ABCG2. In the present study, we analyzed the relationship between single-nucleotide polymorphisms of ABCB1 and ABCG2 genes and raltegravir concentrations in 31 plasma and 14 CSF samples of HIV-infected patients treated with raltegravir-containing regimens. The mean CSF raltegravir concentration was significantly lower in CA (25.5 ng/mL) and AA (<10 ng/mL) genotypes at position 421 in ABCG2 gene compared with CC (103.6 ng/mL) genotype holders (P = 0.016).

AB - Adenosine triphosphate-binding cassette transporter G2 (ABCG2) is expressed on the cerebrospinal fluid (CSF) side of choroid plexus epithelial cells, which form the blood-CSF barrier. Raltegravir was recently identified as a substrate of ABCG2. In the present study, we analyzed the relationship between single-nucleotide polymorphisms of ABCB1 and ABCG2 genes and raltegravir concentrations in 31 plasma and 14 CSF samples of HIV-infected patients treated with raltegravir-containing regimens. The mean CSF raltegravir concentration was significantly lower in CA (25.5 ng/mL) and AA (<10 ng/mL) genotypes at position 421 in ABCG2 gene compared with CC (103.6 ng/mL) genotype holders (P = 0.016).

KW - Adenosine triphosphate-binding cassette transporter G2

KW - Antiretroviral therapy

KW - Blood-cerebrospinal fluid barrier

KW - Cerebrospinal fluid concentrations

KW - Raltegravir

UR - http://www.scopus.com/inward/record.url?scp=84904465734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904465734&partnerID=8YFLogxK

U2 - 10.1097/QAI.0000000000000222

DO - 10.1097/QAI.0000000000000222

M3 - Article

C2 - 24872134

AN - SCOPUS:84904465734

VL - 66

SP - 484

EP - 486

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 5

ER -